» Articles » PMID: 36707895

Primary Headache Types in Adult Epilepsy Patients

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2023 Jan 28
PMID 36707895
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Headache is among the most common comorbidities in epilepsy. This study examined the distribution of different primary headache disorders in a large cohort of patients with diagnosed epilepsy. Headache types were analysed with regard to gender, type of epilepsy and antiepileptic drugs (AEDs).

Methods: In this prospective single-centre study, 500 patients with epilepsy (250 female, mean age: 45.52 ± 17.26 years) were evaluated with regards to primary headache types using a validated German headache questionnaire categorizing for migraine (MIG), tension-type headache (TTH) or trigeminal autonomic cephalalgias (TAC), their combinations and unclassifiable headache. Data regarding type of epilepsy, seizure-associated headache, AED treatment and seizure freedom were collected.

Results: Of 500 patients with epilepsy, 163 (32.6%) patients (108 female and 55 male) reported suffering from headaches at least 1 day per month. MIG (without aura, with aura) and TTH were the most frequent headache type (MIG 33.1%, TTH 33.1%). Female epilepsy patients reported headaches significantly more often than male patients (x = 8.20, p = 0.0042). In contrast, the type of epilepsy did not significantly affect headache distribution. Of 163 patients with headache, 66 (40.5%) patients reported seizure-associated headache and AEDs were used by 157 patients. Of importance, patients with AED monotherapy suffered from MIG less often when compared to patients on polytherapy (x = 4.79, p = 0.028).

Conclusion: MIG and TTH are the most common headache types in epilepsy patients and headache is more frequent among female epilepsy patients. Monotherapy in AEDs might have a beneficial effect on the frequency of headache compared to polytherapy.

Citing Articles

Primary Headache Is Related to Reduced Health-Related Quality of Life in Children with Epilepsy.

Schiller K, Schiller V, Kortas A, Unterholzner G, Raffler S, Schimmel M Healthcare (Basel). 2024; 12(4).

PMID: 38391802 PMC: 10887633. DOI: 10.3390/healthcare12040426.


Migraine - a borderland disease to epilepsy: near it but not of it.

Paungarttner J, Quartana M, Patti L, Sklenarova B, Farham F, Jimenez I J Headache Pain. 2024; 25(1):11.

PMID: 38273253 PMC: 10811828. DOI: 10.1186/s10194-024-01719-0.

References
1.
Melo-Carrillo A, Schain A, Strassman A, Burstein R . Activation of Peripheral and Central Trigeminovascular Neurons by Seizure: Implications for Ictal and Postictal Headache. J Neurosci. 2020; 40(27):5314-5326. PMC: 7329305. DOI: 10.1523/JNEUROSCI.0283-20.2020. View

2.
Diener H, Tfelt-Hansen P, Dahlof C, Lainez M, Sandrini G, Wang S . Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004; 251(8):943-50. DOI: 10.1007/s00415-004-0464-6. View

3.
Fritsche G, Hueppe M, Kukava M, Dzagnidze A, Schuerks M, Yoon M . Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias. Headache. 2007; 47(4):546-51. DOI: 10.1111/j.1526-4610.2007.00758.x. View

4.
Brandes J, Saper J, Diamond M, Couch J, Lewis D, Schmitt J . Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004; 291(8):965-73. DOI: 10.1001/jama.291.8.965. View

5.
Keezer M, Sisodiya S, Sander J . Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2015; 15(1):106-15. DOI: 10.1016/S1474-4422(15)00225-2. View